About MDxHealth
MDxHealth is a company based in Irvine (United States) founded in 2003.. The company has 312 employees as of December 31, 2024. MDxHealth has completed 1 acquisition, including NovioGendix. MDxHealth offers products and services including Select mdx, Confirm mdx, Genomic Prostate Score, and Resolve mdx. MDxHealth operates in a competitive market with competitors including Promaxo, Opko Health, Life Length, Gregor Diagnostics and Cancer Targeted Technology, among others.
- Headquarter Irvine, United States
- Employees 312 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mdxhealth Sa
-
Annual Revenue
$90.05 M28.29as on Dec 31, 2024
-
Net Profit
$-38.07 M11.67as on Dec 31, 2024
-
EBITDA
$-16.06 M19.73as on Dec 31, 2024
-
Latest Funding Round
$14 M (USD), Post-IPO
Apr 27, 2020
-
Investors
Kreos Capital
& 5 more
-
Employee Count
312
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MDxHealth
MDxHealth is a publicly listed company on the NASDAQ with ticker symbol MDXH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MDxHealth
MDxHealth offers a comprehensive portfolio of products and services, including Select mdx, Confirm mdx, Genomic Prostate Score, and Resolve mdx. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts tumor aggressiveness for prostate cancer risk assessment.
Genomic test for confirming prostate cancer progression risks.
Assesses prostate cancer metastasis and mortality risks.
Urine-based test for detecting infectious diseases.
Unlock access to complete
Funding Insights of MDxHealth
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $14.0M
-
First Round
First Round
(03 May 2011)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Post-IPO - MDxHealth | Valuation |
investors |
|
| Sep, 2019 | Amount | Debt – Conventional - MDxHealth | Valuation |
investors |
|
| Mar, 2019 | Amount | Grant - MDxHealth | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MDxHealth
MDxHealth has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Kreos Capital, European Union and MVM Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location | |
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MDxHealth
MDxHealth has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NovioGendix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Urine-based cancer diagnostic tests
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MDxHealth
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mdxhealth Comparisons
Competitors of MDxHealth
MDxHealth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Promaxo, Opko Health, Life Length, Gregor Diagnostics and Cancer Targeted Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portable MRI for prostate cancer screening is developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic products for prostate cancer assessment are provided.
|
|
| domain | founded_year | HQ Location |
Provides telomere length analysis technology for diagnosis
|
|
| domain | founded_year | HQ Location |
Non-invasive prostate cancer screening is provided via seminal fluid analysis.
|
|
| domain | founded_year | HQ Location |
Cancer Targeted Technology is focused on developing small molecule drugs for cancer diagnosis and treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mdxhealth
Frequently Asked Questions about MDxHealth
When was MDxHealth founded?
MDxHealth was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Where is MDxHealth located?
MDxHealth is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
How many employees does MDxHealth have?
As of Dec 31, 2024, the latest employee count at MDxHealth is 312.
What is the annual revenue of MDxHealth?
Annual revenue of MDxHealth is $90.05M as on Dec 31, 2024.
What does MDxHealth do?
MDxHealth specializes in development of next generation epigenetic prostate cancer tests to help rule out false-negative biopsy results and avoid unnecessary repeated biopsies. Its flagship product ConfirmMDx uses the proprietary DNA methylation platform and biomarkers to assess the need for future biopsies in patients otherwise clear of prostrate cancer. Another closely related product SelectMDx predicts the risk of aggressive cancer using RT-PCR on urine samples to estimate levels of prostrate specific antigens.
Who are the top competitors of MDxHealth?
MDxHealth's top competitors include Promaxo, Opko Health and Cancer Targeted Technology.
What products or services does MDxHealth offer?
MDxHealth offers Select mdx, Confirm mdx, Genomic Prostate Score, and Resolve mdx.
Is MDxHealth publicly traded?
Yes, MDxHealth is publicly traded on NASDAQ under the ticker symbol MDXH.
How many acquisitions has MDxHealth made?
MDxHealth has made 1 acquisition, including NovioGendix.
Who are MDxHealth's investors?
MDxHealth has 6 investors. Key investors include Kreos Capital, European Union, MVM Partners, EIC Fund, and Beste Online Casino België.
What is MDxHealth's ticker symbol?
The ticker symbol of MDxHealth is MDXH on NASDAQ.